Munoz Carlos, Valencia Carla, Scoma Christopher, Fernandez Joel
Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Cardiology, University of South Florida, Morsani College of Medicine, Tampa, USA.
Cureus. 2022 Oct 28;14(10):e30814. doi: 10.7759/cureus.30814. eCollection 2022 Oct.
Early bioprosthetic mitral valve failure is uncommon, but cases can present with symptomatic heart failure and require careful attention and evaluation. Transcatheter valve replacement is a minimally invasive treatment for mitral valve dysfunction that can have a considerable impact, particularly for those who are at high surgical risk or have a history of bioprosthetic valve failure. We present a rare case of significant mitral regurgitation due to the unexpected premature failure of a bioprosthetic valve that was implanted three years prior. This patient was treated with transcatheter mitral valve replacement with the implantation of an Edwards SAPIEN Ultra (Edwards Lifesciences) valve.
早期生物瓣二尖瓣功能障碍并不常见，但病例可能表现为有症状的心衰，需要仔细关注和评估。经导管瓣膜置换术是二尖瓣功能障碍的一种微创治疗方法，可能会产生重大影响，特别是对于那些手术风险高或有生物瓣功能障碍病史的患者。我们报告一例罕见病例，该患者因三年前植入的生物瓣意外过早功能障碍导致严重二尖瓣反流。该患者接受了经导管二尖瓣置换术，植入了爱德华 Sapien Ultra（爱德华生命科学公司）瓣膜。
